Kalirin is Under-Expressed in Alzheimer's Disease Hippocampus
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
To identify genes aberrantly expressed in the brain of individuals with Alzheimer's Disease (AD), we analyzed RNA extracts from the hippocampus and cerebellum from 19 AD patients and 15 age- and sex-matched control subjects. Our analysis identified a number of genes that were over-expressed or under-expressed specifically in AD hippocampus. Among these genes, kalirin was the most consistently under-expressed in AD hippocampus, which was verified by semi-quantitative RT-PCR and real time PCR. Kalirin is predominantly expressed in the brain, particularly in the hippocampus, and plays crucial roles in neuronal stability and growth. Our observation is the first to relate kalirin to AD and a human disease. In addition to kalirin, the genes for voltage-gated Ca++ channel gamma subunit 3 and visinin-like protein 1 (a Ca++ sensor protein) were under-expressed, whereas inositol 1,4,5-triphosphate 3-kinase B was over-expressed in AD hippocampus. Collectively, these differential expressions could severely impair calcium homeostasis. Remarkably, these aberrant gene expressions in AD hippocampus were not observed in AD cerebellum. Furthermore, housekeeping genes such as ribosomal protein genes are not affected by AD. These results provide new insights into the biochemistry of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, mRNA and protein levels of kalirin-7, a key regulator of spine morphogenesis and an upstream activator of PAK in spines, were found to be substantially diminished in the hippocampus of individuals with Alzheimer’s disease71,72, suggesting a role for the kalirin-7–Rac1–PAK pathway in Alzheimer’s disease–associated spine pathology.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [72]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“5 million people in the United States [20].”
BackgroundHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Discovering statistically significant pathways in expression profiling studies
Tian, L., Greenberg, S. A., Kong, S. W., Altschuler, J., Kohane, I. S., & Park, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506577102 · Cited by 648
de Kok, J. B., Roelofs, R. W., Giesendorf, B. A., Pennings, J. L., Waas, E. T., Feuth, T., Swinkels, D. W., & Span, P. N. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700208 · Cited by 580
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
Xia, M., & Hyman, B. T. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029743 · Cited by 269
The channel hypothesis of Alzheimer’s disease: current status
Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R., & Lin, M.-C. (2002) · Peptides · doi:10.1016/s0196-9781(02)00067-0 · Cited by 230
Laws, S. M., Hone, E., Gandy, S., & Martins, R. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01615.x · Cited by 223 · cited 4×
“1) indicate that our AD patients and con-trol subjects reflect the general AD and control populations [27] as described in Materials and Methods (Table 1).”
InfluentialNathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051529 · Cited by 214 · cited 1×
“Since genetic ablation of iNOS protects mice from Alzheimer’s-like disease [35], it is important to know whether kalirin suppresses iNOS in the human brain, which is under investigation in our laboratory.”
BackgroundVoltage-Dependent Calcium Channels
(2006) · Encyclopedia of Pain · doi:10.1007/978-3-540-29805-2_4827 · Cited by 181
GeneChip ® analysis after acute spinal cord injury in rat
Song, G., Cechvala, C., Resnick, D. K., Dempsey, R. J., & Rao, V. L. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00626.x · Cited by 152
Wieland, T., & Mittmann, C. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00326-1 · Cited by 132
Emilsson, L., Saetre, P., & JAZIN, E. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.004 · Cited by 130
Kalirin Inhibition of Inducible Nitric-oxide Synthase
Ratovitski, E. A., Alam, M. R., Quick, R. A., McMillan, A., Bao, C., Kozlovsky, C., Hand, T. A., Johnson, R. C., Mains, R. E., Eipper, B. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.993 · Cited by 121
May, V., Schiller, M. R., Eipper, B. A., & Mains, R. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06980.2002 · Cited by 89
Rabiner, C. A., Mains, R. E., & Eipper, B. A. (2005) · The Neuroscientist · doi:10.1177/1073858404271250 · Cited by 66
Rosi, S., Pert, C. B., Ruff, M. R., McGann-Gramling, K. R., & Wenk, G. L. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.029 · Cited by 65
A unifying hypothesis of alzheimer's disease
Heininger, K. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)83327-8 · Cited by 52
Up-regulation of Glycohydrolases in Alzheimer's Disease Fibroblasts Correlates with Ras Activation
Emiliani, C., Urbanelli, L., Racanicchi, L., Orlacchio, A., Pelicci, G., Sorbi, S., Bernardi, G., & Orlacchio, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303030200 · Cited by 50
Cloning and characterization of the promoter of human Wnt inhibitory factor-1
Reguart, N., He, B., Xu, Z., You, L., Lee, A. Y., Mazières, J., Mikami, I., Batra, S., Rosell, R., McCormick, F. P., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.075 · Cited by 46
Muma, N. A., Mariyappa, R., Williams, K., & Lee, J. M. (2003) · Synapse · doi:10.1002/syn.10153 · Cited by 42
Emilsson, L., Saetre, P., & JAZIN, E. E. (2005) · Synapse · doi:10.1002/syn.20226 · Cited by 40
Kawamura, Y., Kikuchi, A., Takada, R., Takada, S., Sudoh, S., Shibamoto, S., Yanagisawa, K., & Komano, H. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02197.x · Cited by 35
Plasticity in Hippocampal Peptidergic Systems Induced by Repeated Electroconvulsive Shock
Ma, X. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00284-1 · Cited by 33
Inositol phosphates: Does IP4 run a protection racket?
Irvine, R. F. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00086-0 · Cited by 30
Ohkawa, H., Sohma, H., Sakai, R., Kuroki, Y., Hashimoto, E., Murakami, S., & Saito, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00168-0 · Cited by 17
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465
Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration
Stankiewicz, T. R., & Linseman, D. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00314 · Cited by 391
Lin, Y.-C., & Koleske, A. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153204 · Cited by 248
Gene expression profiling in human neurodegenerative disease
Cooper-Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., & Shaw, P. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.156 · Cited by 223
Metadata
- Authors
- Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H.
- Affiliations
- University of Kentucky (US)
- Stanford Medicine (US)
- Corresponding author
- Ji, Tae H.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2007-05-29
- Volume
- 11
- Issue
- 3
- Pages
- 385-397
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W7362354
- Cited by
- 77
- References
- 31
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 9 · 2013: 3 · 2012: 10
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institutes of Health (5r01gm074101-03, 5r01hd018702-30)
- National Institute on Aging (P50AG005144, 5 P50 AG05144)
- National Institute of General Medical Sciences (R01 GM74101)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD18702)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Kalirin, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Cerebellum, Female, Hippocampus, Humans, Male, RNA, Gene Expression, Protein Serine-Threonine Kinases, Reverse Transcriptase Polymerase Chain Reaction, Guanine Nucleotide Exchange Factors, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.